LY3041658

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3041658, covering 2017-02-15 to 2023-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3041658 in Adults With Hidradenitis Suppurativa [Phase 2]